经内镜逆行胰胆管造影术后急性胰腺炎与高淀粉酶血症对比观察

马敏; 周中银

doi:10.3969/j.issn.1001-5256.2020.02.033

经内镜逆行胰胆管造影术后急性胰腺炎与高淀粉酶血症对比观察

DOI: 10.3969/j.issn.1001-5256.2020.02.033

马敏,
周中银

武汉大学人民医院消化内科

基金项目:

湖北省科学技术计划资助项目(2013BKB013)；

详细信息

中图分类号: R576
计量
- 文章访问数: 1203
- HTML全文浏览量: 46
- PDF下载量: 176
- 被引次数: 0
出版历程
- 收稿日期: 2019-09-09
- 出版日期: 2020-02-20

A comparative analysis of acute pancreatitis and hyperamylasemia after endoscopic retrograde cholangiopancreatography

Department of Gastroenterology,Renmin Hospital of Wuhan University

Research funding:

摘要

摘要:
目的比较经内镜逆行胰胆管造影术（ERCP）后急性胰腺炎（PEP）与高淀粉酶血症（PEHA）患者的临床特点及影响因素,为预防病情进展提供依据。方法选取武汉大学人民医院2017年1月-2019年8月住院行ERCP的患者117例,所有患者术前均预防性使用双氯芬酸钠栓塞肛。术后发生PEHA组77例,PEP组40例,比较2组患者临床特点及影响因素。符合正态分布的计量资料2组间比较采用t检验;不符合正态分布的计量资料2组间比较采用Mann-Whitney U检验;计数资料2组间比较采用χ2检验;采用多因素logistic回归分析PEP的独立影响因素。结果术前ALP（Z=-2. 518,P=0. 012）、GGT（Z=-2. 313,P=0. 021）、TBil（Z=-2. 978,P=0. 003）、DBil（Z=-3. 069,P=0. 002）水平及术中是否行导丝进入胰管检查（χ2=4. 176,P=0. 041）在两组之间差异显著。进一步logistic回归分析结果显示,导丝进入胰管次数≥3次[优势比（OR）=2. 469,95%可信区间（95%C...
- 胰胆管造影术,内窥镜逆行 /
- 高淀粉酶血症 /
- 急性胰腺炎
Abstract:
Objective To investigate the clinical features of patients with acute pancreatitis versus hyperamylasemia after endoscopic retrograde cholangiopancreatography( ERCP) and related influencing factors,and to provide a basis for preventing disease progression. Methods A retrospective analysis was performed for the clinical data of 117 patients who underwent ERCP in Renmin Hospital of Wuhan University from January 2017 to August 2019,and all patients were given the preventive use of diclofenac sodium suppository before surgery. After surgery,77 patients developed hyperamylasemia and 40 developed acute pancreatitis,and the two groups were compared in terms of clinical features and influencing factors. The t-test was used for comparison of normally distributed continuous data between two groups,and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups; the chi-square test was used for comparison of categorical data between two groups; a multivariate logistic regression analysis was used to investigate the independent risk factors for post-ERCP pancreatitis( PEP). Results There were significant differences between the two groups in preoperative levels of alkaline phosphatase( ALP)( Z =-2. 518,P = 0. 012),gamma-glutamyl transpeptidase( Z =-2. 313,P = 0. 021),total bilirubin( TBil)( Z =-2. 978,P = 0. 003),and direct bilirubin( Z =-3. 069,P = 0. 002) and presence or absence of guide wire insertion into the pancreatic duct during surgery( χ2= 4. 176,P = 0. 041). Further logistic regression analysis showed that the number of times of guide wire insertion into the pancreatic duct ≥3( odds ratio [OR]= 2. 469,95% confidence interval [CI]: 1. 199-5. 188,P = 0. 047),ALP< 125 U/L( OR = 5. 499,95% CI: 1. 452-18. 830,P = 0. 012),and TBil < 22 umol/L( OR = 4. 249,95% CI: 1. 023-17. 648,P =0. 046) were independent risk factors for PEP. Conclusion Although patients are given the preventive use of diclofenac sodium suppository before surgery,the patients with normal levels of ALP and TBil before surgery and repeated guide wire insertion into the pancreatic duct during surgery are more likely to develop PEP,which should be taken seriously by surgeons. Early intervention measures before and after surgery based on patients' conditions can reduce the progression of post-ERCP hyperamylasemia to PEP,reduce the development of moderate-to-severe PEP,and improve patients' prognosis.
- cholangiopancreatography,endoscopic retrograde /
- hyperamylasemia /
- acute pancreatitis

HTML全文

参考文献(21)

[1] BAIU I,VISSER B. Endoscopic retrograde cholangiopancreatography[J]. JAMA,2018,320(19):2050.

[2] KOCHAR B,AKSHINTALA VS,AFGHANI E,et al. Incidence,severity,and mortality of post-ERCP pancreatitis:A systematic review by using randomized,controlled trials[J]. Gastrointest Endosc,2015,81(1):143-149.

[3] PEKGÖZ M. Post-endoscopic retrograde cholangiopancreatography pancreatitis:A systematic review for prevention and treatment[J]. World J Gastroenterol,2019,25(29):4019-4042.

[4] MINE T,MORIZANE T,KAWAGUCHI Y,et al. Clinical practice guideline for post-ERCP pancreatitis[J]. J Gastroenterol,2017,52(9):1013-1022.

[5] SHIH HY,HSU WH,KUO CH. Post endoscopic retrograde cholangiopancreatography pancreatitis[J]. Kaohsiung J Med Sci,2019,35(4):195-201.

[6] ZHU YZ,WANG Y,ZHU C,et al. An excerpt of JSGE clinical practice guideline for post-ERCP pancreatitis(2017)[J]. J Clin Hepatol,2017,33(12):2283-2287.(in Chinese)朱奕舟，王颖，朱昌，等．《2017年日本胃肠病学会经内镜逆行胰胆管造影术后胰腺炎临床实践指南》摘译[J]．临床肝胆病杂志，2017,33(12):2283-2287.

[7] LIN Y,LIU X,CAO DQ,et al. Analysis of risk factors and prevention strategies of post-ERCP pancreatitis[J]. Eur Rev Med Pharmacol Sci,2017,21(22):5185-5190.

[8] COTTON PB,LEHMAN G,VENNES J,et al. Endoscopic sphincterotomy complications and their management:An attempt at consensus[J]. Gastrointest Endosc,1991,37(3):383-393.

[9] MORALES SJ,SAMPATH K,GARDNER TB. A review of prevention of post-ERCP pancreatitis[J]. Gastroenterol Hepatol(N Y),2018,14(5):286-292.

[10] ISHIKAWA-KAKIYA Y,SHIBA M,MARUYAMA H,et al. Risk of pancreatitis after pancreatic duct guidewire placement during endoscopic retrograde cholangiopancreatography[J].PLo S One,2018,13(1):e0190379.

[11] HE QB,XU T,WANG J,et al. Risk factors for post-ERCP pancreatitis and hyperamylasemia:A retrospective singlecenter study[J]. J Dig Dis,2015,16(8):471-478.

[12] ZHENG L,WANG X,TAO Q,et al. Different pattern of risk factors for post-ERCP pancreatitis in patients with biliary stricture[J]. Scand J Gastroenterol,2018,53(5):604-610.

[13] GÜNGÖR B,CAGLAYAN K,POLAT C,et al. The predictivity of serum biochemical markers in acute biliary pancreatitis[J].ISRN Gastroenterol,2011,2011:279607.

[14] TIAN T,SHI ZH. Relationship between antioxidant system of bilirubin and ischemic stroke[J]. Chin J Rehabil Theory Pract,2015,21(10):1178-1181.(in Chinese)田婷，石正洪．胆红素抗氧化系统与缺血性脑卒中的关系[J]．中国康复理论与实践，2015,21(10):1178-1181.

[15] HE Q,WANG LW. Nutritional support and somatostatin combined with ulinastatin in the treatment of severe acute pancreatitis[J]. Clin J Med Offic,2018,46(3):248-250,254.(in Chinese)何清，王立为．营养支持、生长抑素联合乌司他丁治疗重症急性胰腺炎疗效分析[J]．临床军医杂志，2018,46(3):248-250,254.

[16] ZHU K,WANG JP,SU JG. Prophylactic ulinastatin administration for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis:A meta-analysis[J]. Exp Ther Med,2017,14(4):3036-3056.

[17] WANG G,XIAO G,XU L,et al. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia:A systematic review and meta-analysis[J]. Pancreatology,2018,18(4):370-378.

[18] Chinese Digestive Endoscopist Committee,Chinese Endoscopist Association,Chinese Physicians’Association,Pancreatic Disease Committee,Chinese Physicians’Association,Editorial Department of Chinese Journal of Digestion,et al. Expert consensus on perioperative medication for endoscopic retrograde cholangiopancreatography[J]. J Clin Hepatol, 2018, 34(12):2555-2562.(in Chinese)中国医师协会内镜医师分会消化内镜专业委员会，中国医师协会胰腺病专业委员会，《中华消化杂志》，等．经内镜逆行胰胆管造影术围手术期用药专家共识意见[J]．临床肝胆病杂志，2018,34(12):2555-2562.

[19] WU D,WAN J,XIA L,et al. The efficiency of aggressive hydration with lactated ringer solution for the prevention of postERCP pancreatitis:A systematic review and Meta-analysis[J]. J Clin Gastroenterol,2017,51(8):e68-e76.

[20] SERRANO JPR,de MOURA DTH,BERNARDO WM,et al. Nonsteroidal anti-inflammatory drugs versus placebo for post-endoscopic retrograde cholangiopancreatography pancreatitis:A systematic review and meta-analysis[J]. Endosc Int Open,2019,7(4):e477-e486.

[21] MOK S,HO HC,SHAH P,et al. Lactated Ringer’s solution in combination with rectal indomethacin for prevention of postERCP pancreatitis and readmission:A prospective randomized,double-blinded,placebo-controlled trial[J]. Gastrointest Endosc,2017,85(5):1005-1013.

施引文献

资源附件(0)

访问统计